Williams Laura A

Average Profitability
247.57%
Insider Buys Quantity
1
Insider Buys Sum
$1,856.40
Insider Sells Quantity
13
Insider Sells Sum
$1.72M

Insider Activity of Williams Laura A

According to the SEC Form 4 filings, Williams Laura A, being in a position of

  1. Chief Medical Officer at Ardelyx, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 201958 shares for $1.49M,
    over all time since 2022-08-22, has bought 3000 shares for $1,856, and sold 264154 shares for $1.72M.

The largest purchase of all time was on 2022-08-31 and amounted to 3000 shares of Ardelyx, Inc. for $1,856.

The largest sale of all time was on 2024-06-05 and amounted to 145000 shares of Ardelyx, Inc. for $1.03M.

Biography of Williams Laura A

No biography is available at this moment.

2024-08-20SaleArdelyx, Inc.
ARDX
Chief Medical Officer
7,412
0.003%
$5.86$43,437-1.96%
2024-06-05SaleArdelyx, Inc.
ARDX
Chief Medical Officer
145,000
0.0619%
$7.12$1.03M-15.85%
2024-05-21SaleArdelyx, Inc.
ARDX
Chief Medical Officer
4,794
0.0021%
$7.81$37,446-21.83%
2024-05-03SaleArdelyx, Inc.
ARDX
Chief Medical Officer
39,949
0.0164%
$8.35$333,574-29.54%
2024-02-20SaleArdelyx, Inc.
ARDX
Chief Medical Officer
4,803
0.0021%
$8.75$42,008-24.44%
2023-11-20SaleArdelyx, Inc.
ARDX
Chief Medical Officer
2,581
0.0011%
$4.36$11,259+49.2%
2023-11-15SaleArdelyx, Inc.
ARDX
Chief Medical Officer
25,000
0.0111%
$4.00$99,998+66.8%
2023-08-21SaleArdelyx, Inc.
ARDX
Chief Medical Officer
2,591
0.0012%
$3.55$9,203+76.82%
2023-06-27SaleArdelyx, Inc.
ARDX
Chief Medical Officer
25,000
0.012%
$3.35$83,633+81.85%
2023-05-23SaleArdelyx, Inc.
ARDX
Chief Medical Officer
2,583
0.0013%
$3.65$9,436+28.57%
2023-02-21SaleArdelyx, Inc.
ARDX
Chief Medical Officer
3,187
0.0016%
$3.00$9,564+37.93%
2022-11-22SaleArdelyx, Inc.
ARDX
Chief Medical Officer
1,241
0.0008%
$1.95$2,419+100%
2022-08-31PurchaseArdelyx, Inc.
ARDX
Chief Medical Officer
3,000
0.0012%
$0.62$1,856+247.57%
2022-08-22SaleArdelyx, Inc.
ARDX
Chief Medical Officer
13
<0.0001%
$0.98$13+221.5%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.